返回 Agenda
International Pharmacovigilance
Session Chair(s)
Esteban Herrero-Martinez, PHD
Director Regulatory Policy and Intelligence
Novartis Pharmaceuticals UK Limited, United Kingdom
Pharmacovigilance is of increasing focus and importance internationally. Although welcome, huge variations in approach, legislative maturity, resource and fast-moving change are a challenge for all. We all have a responsibility to support development of effective pharmacovigilance systems globally to protect patients and support medicine delivery. With multiple activities worldwide and scarce resources, important key stakeholders must understand each other’s activities and support each other to achieve the same ultimate objectives.
Speaker(s)
Panel Discussion
Amr Saad
Founder, The Egyptian Pharmacovigilance Center (EPVC) , Egypt
Former Associate Minister of Health for Pharmaceutical Affairs
Panel Discussion
Bahija Gouimi
AMAL, Morocco
Founder
Panel Discussion
Raj Long, MED, MSC
Bill and Melinda Gates Foundation, United Kingdom
Deputy Director, Safety and Pharmacovigilance
Panel Discussion
Emer Cooke, MBA, MSC
European Medicines Agency, Netherlands
Chair, ICMRA; Executive Director
Panel Discussion
June Raine, MD, MSC, FRCP
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Executive
Panel Discussion
Sue Rees, MS
Sue Rees Consultancy Ltd, United Kingdom
Director
Panel Discussion
Xavier Kurz, MD, PHD, MSC
European Medicines Agency, Netherlands
Head of Data Analytics Workstream